AIM ImmunoTech has submitted a proposal to Sterling Pharma Solutions for the cGMP manufacture of PolyI and Poly C12U drug substance batches. This submission outlines a detailed project plan for the scale-up and manufacturing of polynucleotides in aqueous frozen solution at Sterling's Dudley site.